Amna Ibrahim

7PUBLICATIONS
28CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Avionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 05, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.

Jaleh Fallah, Sundeep Agrawal, Haley Gittleman

|Jun 21, 2022
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.

Jaleh Fallah, Michael H Brave, Chana Weinstock

|Oct 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.

Shaily Arora, Preeti Narayan, Christy L Osgood

|Oct 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.

Shaily Arora, Preeti Narayan, Gwynn Ison

|Aug 21, 2021
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.

Elaine Chang, Chana Weinstock, Lijun Zhang

|Jun 12, 2021
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples.

Anup K Amatya, Mallorie H Fiero, Erik W Bloomquist

Pageof 2